Greg Hoffman
Impact in
-
- Hippo pathway signaling and YAP/TAZ
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- Protein Degradation and Inhibitors 1
-
- Chronic Myeloid Leukemia Treatments 1
- Acute Myeloid Leukemia Research 1
- Co-authors
- Xuxin Liu (1 shared paper)Jun S. Liu (1 shared paper)Aylwin Ng (1 shared paper)Bénédicte F. Py (1 shared paper)Junying Yuan (1 shared paper)Ramnik J. Xavier (1 shared paper)Marta M. Lipinski (1 shared paper)Wen Zhou (1 shared paper)
- Journals
- Developmental Cell (1 paper)Leukemia (1 paper)Organizational Dynamics (1 paper)Journal of Biological Chemistry (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Greg Hoffman
7 papers receiving 385 citations
Peers
Comparison fields: 5 of 60
- Physiology 24
- Cell Biology 78
- Hematology 52
- Epidemiology 158
- Molecular Biology 232
Countries citing papers authored by Greg Hoffman
This map shows the geographic impact of Greg Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Hoffman more than expected).
Fields of papers citing papers by Greg Hoffman
This network shows the impact of papers produced by Greg Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Hoffman. The network helps show where Greg Hoffman may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 182 | |
| 2 | 2016 | 84 | |
| 3 | 2016 | 61 | |
| 4 | 2015 | 43 | |
| 5 | 2004 | 10 | |
| 6 | Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5(or 4)-[3,3-bis( 2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196). | 1968 | 7 |
| 7 | Adaptation of a colorimetric determination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) and 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) to blood. | 1969 | 1 |
About Greg Hoffman
Greg Hoffman is a scholar working on Molecular Biology, Hematology, Cancer Research, Organic Chemistry and Strategy and Management, having authored 7 papers that have together received 388 indexed citations. Recurring topics across this work include Electrochemical sensors and biosensors (1 paper), MicroRNA in disease regulation (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), Protein Degradation and Inhibitors (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Lung Cancer Treatments and Mutations (1 paper), Acute Myeloid Leukemia Research (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Physiology (24 citations), Cell Biology (78 citations), Hematology (52 citations), Epidemiology (158 citations) and Molecular Biology (232 citations). Greg Hoffman has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Xuxin Liu, Jun S. Liu, Aylwin Ng, Bénédicte F. Py, Junying Yuan, Ramnik J. Xavier, Marta M. Lipinski, Wen Zhou, John Blenis and Emily Hsu. Their work appears in journals such as Developmental Cell, Leukemia, Organizational Dynamics, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.